Larvol Delta - Phase-I-Study-to-Evaluate-the-Safety-Tolerability-and-Pharmacokinetics-of-Single-and-Multiple-Ascending-Oral-Doses-of-Novel-5HT2C-Agonist-BMB101-in-Fed-and-Fasted-Adult-Healthy-Human-Volunteers

Fintepla (low-dose fenfluramine) - UCB

BMB-101 - Bright Minds

https://eppro01.ativ.me/web/page.php?page=session&project=AES24&id=2894192

Alex Vasilkevich, MSc; Jianmin Duan, PhD; Mark Smith, MD; Jan Pedersen, PhD

Nov 26, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next